Insufficient scRNA-seq data for expression of CRYAA at single-cell level.
Insufficient scRNA-seq data for expression of CRYAA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 82% | 95.24 | 73 / 89 | 0% | 0.03 | 4 / 901 |
liver | 62% | 3.08 | 139 / 226 | 2% | 0.04 | 9 / 406 |
brain | 22% | 0.41 | 578 / 2642 | 0% | 0 | 0 / 705 |
stomach | 18% | 0.30 | 65 / 359 | 0% | 0 | 0 / 286 |
skin | 18% | 0.28 | 323 / 1809 | 0% | 0 | 0 / 472 |
thymus | 18% | 0.26 | 115 / 653 | 0% | 0 | 0 / 605 |
prostate | 16% | 0.19 | 38 / 245 | 0% | 0 | 0 / 502 |
esophagus | 15% | 0.20 | 221 / 1445 | 0% | 0 | 0 / 183 |
ovary | 15% | 0.17 | 27 / 180 | 0% | 0 | 0 / 430 |
spleen | 15% | 0.19 | 35 / 241 | 0% | 0 | 0 / 0 |
adipose | 14% | 0.18 | 167 / 1204 | 0% | 0 | 0 / 0 |
uterus | 14% | 0.19 | 23 / 170 | 0% | 0 | 0 / 459 |
breast | 13% | 0.21 | 61 / 459 | 0% | 0.00 | 1 / 1118 |
lung | 13% | 0.16 | 77 / 578 | 0% | 0 | 0 / 1155 |
intestine | 13% | 0.16 | 125 / 966 | 0% | 0 | 0 / 527 |
adrenal gland | 12% | 0.15 | 31 / 258 | 0% | 0 | 0 / 230 |
peripheral blood | 11% | 0.16 | 106 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 11% | 1.10 | 9 / 80 |
muscle | 10% | 0.11 | 77 / 803 | 0% | 0 | 0 / 0 |
bladder | 10% | 0.14 | 2 / 21 | 0% | 0 | 0 / 504 |
heart | 9% | 0.11 | 80 / 861 | 0% | 0 | 0 / 0 |
pancreas | 9% | 0.10 | 30 / 328 | 0% | 0 | 0 / 178 |
blood vessel | 8% | 0.09 | 103 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002088 | Biological process | lens development in camera-type eye |
GO_0007601 | Biological process | visual perception |
GO_0032387 | Biological process | negative regulation of intracellular transport |
GO_0009408 | Biological process | response to heat |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050821 | Biological process | protein stabilization |
GO_0042026 | Biological process | protein refolding |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0005198 | Molecular function | structural molecule activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0005212 | Molecular function | structural constituent of eye lens |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CRYAA |
Protein name | Alpha-crystallin A chain Alpha-crystallin A chain (Heat shock protein beta-4) (HspB4) [Cleaved into: Alpha-crystallin A(1-172); Alpha-crystallin A(1-168); Alpha-crystallin A(1-162)] Alpha crystallin A chain |
Synonyms | HSPB4 CRYA1 |
Description | FUNCTION: Contributes to the transparency and refractive index of the lens . In its oxidized form (absence of intramolecular disulfide bond), acts as a chaperone, preventing aggregation of various proteins under a wide range of stress conditions . Required for the correct formation of lens intermediate filaments as part of a complex composed of BFSP1, BFSP2 and CRYAA . . |
Accessions | A0A8C8KJZ9 ENST00000291554.6 P02489 ENST00000398132.1 A0A140G952 E7EWH7 Q71V83 A0A140G955 A0A140G954 ENST00000398133.5 |